- PROFESSOR AND SYSTEM CHAIR | Surgery, Vascular Surgery
- Vascular Surgery
- Hospital Affiliation
- The Mount Sinai Hospital
A graduate of the Mount Sinai School of Medicine, Dr. Marin completed an internship and residency at Columbia-Presbyterian Medical Center in New York; and subsequently went on to pursue a fellowship in vascular surgery at Montefiore Medical Center/Albert Einstein College of Medicine. He remained on the faculty at Albert Einstein until 1996, when he was recruited to Mount Sinai to launch the endovascular aortic surgery program. He was endowed as the Henry Kaufman Professor of Surgery in 1999, and appointed Chief, Division of Vascular Surgery in 2000. In December 2003, Dr. Michael L. Marin was appointed Chairman, Department of Surgery, Mount Sinai School of Medicine and Surgeon-in-Chief of The Mount Sinai Medical Center. In 2007, he was named The Julius H. Jacobson II, M.D. Professor of Vascular Surgery.
Dr. Marin has revolutionized modern vascular surgery. In 1992, in New York, together with Dr. Juan Parodi from Argentina, he performed a minimally invasive repair of an abdominal aortic aneurysm under local anesthesia in an 80 year old man who had multiple medical comorbidities. This event, the first such procedure ever performed in the United States, sparked the rapid development of new treatments by Dr. Marin and other physicians from around the world for the minimally invasive treatment of vascular disease. Application of these techniques and new devices have been extended by Dr. Marin to virtually all areas of arterial vascular disease. Using these minimally invasive stent graft techniques and devices, Dr. Marin performed the world’s first minimally invasive repair of a popliteal and iliac artery aneurysms and, in 1994, performed the world’s first endovascular repair of a ruptured abdominal aortic aneurysm.
Inventions and techniques resulting from Dr. Marin’s work formed the basis of 12 important U.S. patents. In 1997, he founded the Teramed Corporation to advance the development and manufacturing of aortic stent graft devices. Teramed was acquired by Johnson & Johnson Corporation in 2001.
An active clinician and teacher, Dr. Marin has contributed extensively to medical literature, including 200 original communications in peer-reviewed journals and more than 60 book chapters. He has served on the editorial boards of the major surgery journals, and has shared his ideas and developments as an invited lecturer throughout the United States and around the world. He has also made over 300 presentations at scientific meetings in the United States and abroad. Additionally, he holds memberships in most regional, national and international professional societies. His achievements have garnered awards from such groups as the American Society of Gastroenterology, The Society for Vascular Surgery and The Peripheral Vascular Surgery Society.In the News
Dr. Marin and his work with Preventing Aortic Aneurysms were recently profiled in The Daily News feature The DailyCheck Up. View the PDF.
American Board of Surgery
- Abdominal Aortic Aneurysm Repair
- Aortic Aneurysm
- Aortic Aneurysm Repair/Removal
- Carotid Artery Endarterectomy
- Carotid Artery Stenosis
Multi-Disciplinary Training Area
Biophysics and Systems Pharmacology [BSP]
MD, Mount Sinai School of Medicine
Columbia-Presbyterian Medical Ctr.
Fellowship, Vascular Surgery
Montefiore Medical Center
The Jacobi Medallion
The Mount Sinai Alumni
New York Magazine
Saul Horowitz, Jr., Memorial Award
The Mount Sinai Hospital
4th Dardik Education and Research Award
Peripheral Vascular Surgery Society
The Liebig Foundation Award
The Society for Vascular Surgery
Blakemore Surgical Research Prize
Columbia-Presbyterian Medical Center
Basic Science Achievement Award
Mount Sinai School of Medicine
National Institutes of Health
Rorer Science Award
The American College of Gastroenterology
Faires PL, Morrissey NJ, Teodorescu VJ, Hollier LH, Marin M. Endovascular treatment of abdominal aortic aneurysms. Mt Sinai J Med 2003; 70: 420-426.
Chun J, Sterry TP, Zhang WX, Wolfeld MB, Silver L, Teodorescu VJ, Marin ML. Rat Epigastric Flow-Through Flap as a Modulated Arteriovenous Fistula: Model for the Radial Artery Flow-Through Flap in Distal Arterial Bypass. J Reconstr Micros Surg 2003; 19: 387-391.
Faries PL, Agarwal G, Lookstein R, Bernheim JW, Cayne NS, Cadot H, Goldman J, Kent KC, Hollier LH, Marin ML. Use of Cine Magnetic Resonance Angiography in Quantifying Aneurysm Pulsatility Associated with Endoleak. J Vasc Surg 2003; 38: 652-656.
Faries PL, Briggs VL, Bernheim J, Kent KC, Hollier LH, Marin ML. Increased recognition of type II endoleaks using a modified intraoperative angiographic protocol: implications for intermittent endoleak and aneurysm expansion. Ann Vasc Surg 2003; 17: 608-614.
Carroccio A, Ellozy S, Spielvogel D, Marin ML, Hollier LH. Endovascular stent grafting of thoracic aortic aneurysms. Ann Vasc Surg 2003; 17: 473-478.
Morrissey NJ, Goldman J, Fallon JT, Faires PL, Marin ML, Hollier LH. Endovascular Aortic Biopsy in the Diagnosis of Takayasu Arteritis. J Endovasc Ther 2003; 10(1): 136-140.
Carroccio A, Marin ML, Ellozy S, Hollier LH. Pathophysiology of paraplegia following endovascular thoracic aortic aneurysm repair. J Card Surg 2003 Jul-Aug; 18(4): 359-366.
Marin ML, Hollier LH, Ellozy SH, Spielvogel D, Mitty H, Griepp R, Loostein RA, Carroccio A, Morrissey N, Teodorescu V, Jacobs TS, Minor M, Sheahan CM, Chae KS, Oak J, Cha A. Endovascular Stent Graft Repair of Abdominal and Thoracic Aortic Aneurysms: A Ten-Year Experience with 817 Patients. Ann Surg 2003; 238: 586-595.
Ellozy SH, Carroccio A, Minor ME, Jacobs T, Chae KS, Cha A, Agarwal G, Goldstein B, Morrissey NJ, Spielvogel D, Lookstein RA, Teodorescu VJ, Hollier LH, Marin ML. Challenges of endovascular tube graft repair of thoracic aortic aneurysms: mid-term follow-up and lessons learned. J Vasc Surg 2003 Oct; 38(4): 676-683.
Jacobs T, Teodorescu V, Morrissey N, Carroccio A, Ellozy S, Minor M, Hollier LH, Marin ML. The endovascular repair of abdominal aortic aneurysm: an update analysis of structural failure modes of endovascular stent grafts. Semin Vasc Surg 2003 June; 16(2): 103-112.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Marin during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- W. L. Gore & Associates, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.